You are here:Home-Chemical Inhibitors & Agonists-GPCR-Prostaglandin Receptor-OC000459
OC000459

Chemical Structure : OC000459

CAS No.: 851723-84-7

OC000459 (Timapiprant)

Catalog No.: PC-38844Not For Human Use, Lab Use Only.

OC000459 is a potent, selective, and orally active D prostanoid receptor 2 (DP2, CRTH2) antagonist with Ki of 13/3 nM for human/recombinant DP2, respectively.

Packing Price Stock Quantity
25 mg $178 In stock
50 mg $298 In stock
100 mg $428 In stock
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

OC000459 (Timapiprant) is a potent, selective, and orally active D prostanoid receptor 2 (DP2, CRTH2) antagonist with Ki of 13/3 nM for human/recombinant DP2, respectively.
OC000459 does not interfere with the ligand binding properties or functional activities of other prostanoid receptors (prostaglandin E1-4 receptors, D1, thromboxane receptor, prostacyclin receptor, and prostaglandin F receptor).
OC000459 inhibited chemotaxis (IC50= 28 nM) of human Th2 lymphocytes and cytokine production (IC50=19 nM) by human Th2 lymphocytes.
OC000459 competitively antagonized eosinophil shape change responses induced by PGD₂ in both isolated human leukocytes (pK(B)=7.9) and human whole blood (pK(B)=7.5) but did not inhibit responses to eotaxin, 5-oxo-eicosatetraenoic acid, or complement component C5a.
OC000459 is orally bioavailable in rats and effective in inhibiting blood eosinophilia induced by 13,14-dihydro-15-keto-PGD₂ (DK-PGD₂) with ED50 of 0.04 mg/kg (p.o.) and airway eosinophilia in response to an aerosol of DK-PGD₂ in guinea pigs (ED50=0.01 mg/kg p.o.).

Physicochemical Properties

M.Wt 348.377
Formula C21H17FN2O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

5-fluoro-2-methyl-3-(2-quinolinylmethyl)-1H-indole-1-acetic acid

References

1. Pettipher R, et al. J Pharmacol Exp Ther. 2012 Feb;340(2):473-82.

2. Barnes N, et al. Clin Exp Allergy. 2012 Jan;42(1):38-48.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: